Aclarion Inc Ordinary Shares ACON
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs
-
Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026
-
Aclarion to Present at the 20th Annual LD Micro Main Event
-
Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
-
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
-
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site
-
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process
-
Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 2.88M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 34.09
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Value
- Total Number of Employees
- 11
- Website
- https://www.aclarion.com
Valuation
|
Metric
|
ACON
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.28 |
Price/Sales | 34.09 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ACON
|
|---|---|
Quick Ratio | 15.73 |
Current Ratio | 16.20 |
Interest Coverage | — |
Quick Ratio
ACON
Profitability
|
Metric
|
ACON
|
|---|---|
Return on Assets (Normalized) | −56.76% |
Return on Equity (Normalized) | −59.83% |
Return on Invested Capital (Normalized) | −64.44% |
Return on Assets
ACON
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| LOCK|B&@T??D | LOCK|xyM | $52B | |||
| Pro Medicus Ltd
PMCUF
| — | LOCK|??DNS | $15B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | LOCK|?%%m | $15B | |||
| Tempus AI Inc Class A common stock
TEM
| — | LOCK|@r | $12B | |||
| BrightSpring Health Services Inc
BTSG
| — | LOCK|BfW& | $12B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | LOCK|gW^Z | $9B | |||
| HealthEquity Inc
HQY
| — | LOCK|Vm%c | $9B | |||
| M3 Inc
MTHRF
| — | LOCK|$HLb? | $8B | |||
| M3 Inc ADR
MTHRY
| — | LOCK|z>!K | $8B | |||
| Doximity Inc Class A
DOCS
| — | LOCK|#x | $6B |
United States